Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02898103 · ClinicalTrials.gov registry record · NA

Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT02898103 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02898103, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The moderate-to-severe pain many patients experience following orthopedic surgery is often treated with opioids, which are associated with side effects such as nausea/vomiting, sedation, and respiratory depression (and a risk of abuse). Potent site-specific analgesia with fewer side effects may be provided with a "continuous peripheral nerve block," which involves the percutaneous insertion of a catheter adjacent to the peripheral nerve(s) supplying a surgical site. Local anesthetic is introduced via the catheter. However, there are major problems with continuous nerve blocks that have dramatically limited their use outside academic centers. Percutaneous peripheral nerve stimulation (PNS) or "nerve modulation" is an alternative method of pain control involving the insertion of an electrical lead through an introducing needle-obviating an open surgical incision for placement-followed by the introduction of electric current to produce analgesia. This modality has been used to treat chronic pain, but it has not been evaluated with a randomized, controlled study when applied to acute pain management (post-surgical analgesia). This temporary therapy has multiple theoretical benefits over existing analgesics, such as a lack of systemic side effects (e.g., nausea, respiratory depression), an absence of induced muscle weakness, and a reduced risk of adverse events (e.g. infection). The purpose of the proposed randomized, double-masked, placebo-controlled, crossover, feasibility study is to explore the possibility of treating postoperative pain with ultrasound-guided percutaneous PNS and, if so, to help power a subsequent definitive randomized, controlled trial.

Interventions

  • DEVICE Sham stimulation
  • DEVICE Percutaneous peripheral nerve stimulation

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2017-02-24
Est. Completion 2018-09-20
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT02898103

The ClinicalTrials.gov registry entry for NCT02898103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham stimulation is the first listed.

NCT02898103 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02898103 about?

NCT02898103 is a clinical study titled "Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia". The moderate-to-severe pain many patients experience following orthopedic surgery is often treated with opioids, which are associated with side effects such as nausea/vomiting, sedation, and respiratory depression (and a risk of abuse). Potent site-specific analgesia with fewer side effects may be p...

What is the current status of trial NCT02898103?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-02-24. Estimated completion is 2018-09-20.

What interventions are being tested in trial NCT02898103?

The interventions under investigation include: Sham stimulation (DEVICE), Percutaneous peripheral nerve stimulation (DEVICE).

Who is sponsoring clinical trial NCT02898103?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.